Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Intraimmune Therapies, Inc., Boston, MA, United States
Search 27 grants from Anne Messer
Search grants from Intraimmune Therapies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
MSI-FLASH: Paced Respiration for Breast Cancer Survivors
Clinical Intervention Trial
Clinical Data Management
Role of A Conserved RNA Signal, Boxa, in Transcription
U.S. Participation in International School of Physics, Leningrad, September 1991
Recently added grants:
Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application
The role and regulation of Hippo pathway in sarcomagenesis
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
The role of MIF in mitochondrial metabolism and M2-TAM polarization
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42NS038002-02
Application #
6073705
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2002-01-31
Budget Start
2000-02-15
Budget End
2001-01-31
Support Year
2
Fiscal Year
2000
Total Cost
$250,000
Indirect Cost
Institution
Name
Intraimmune Therapies, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant